Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy

Epilepsia

Volumn 41, Issue 12, 2000, Pages 1592-1596

  Lhatoo, S D ^a   Wong, I C K ^a   Polizzi, G ^a   Sander, J W A S ^a  

^a Epilepsy Research Group   (United Kingdom)

Author keywords

Chronic epilepsy; New antiepileptic drugs; Retention rates

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; LAMOTRIGINE; TOPIRAMATE;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; EPILEPSY; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACETIC ACIDS; ADOLESCENT; ADULT; AGE OF ONSET; AGED; AMINES; ANTICONVULSANTS; CHRONIC DISEASE; CYCLOHEXANECARBOXYLIC ACIDS; EPILEPSY; FEMALE; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT DROPOUTS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TRIAZINES;

EID: 0034535755     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Some aspects of prognosis in the epilepsies: A review
2. The impact of new antiepileptic drugs on the prognosis of epilepsy: Seizure freedom should be the ultimate goal
3. New drugs for epilepsy
4. Long term use of lamotrigine and vigabatrin in severe refractory epilepsy: Audit of outcome
5. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy
6. Severe persistent visual field constriction associated with vigabatrin
7. Non-parametric estimation from incomplete observations
8. Regression models and life tables
9. Proposal for revised classification of epilepsy and epileptic syndromes
10. Topiramate in clinical practice: First year's postlicensing experience in a specialist epilepsy clinic
11. Outcomes of add-on treatment with lamotrigine in partial epilepsy
12. Surgical treatment of the epilepsies
13. Is the underlying cause of epilepsy a major prognostic factor for recurrence?